Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.7900 (-2.88%) ($10.5750 - $10.7900) on Wed. Jan. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.76% (three month average) | RSI | 37 | Latest Price | $10.7900(-2.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(32%) IBB(29%) SDY(27%) IFRA(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.88% in a week (0% probabilities). VIXM(-16%) UUP(-10%) VXX(-7%) TBT(-1%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.88% (StdDev 3.76%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.6(1.79%) | 10 Day Moving Average | $10.37(4.05%) | 20 Day Moving Average | $10.79(0%) | To recent high | -23.1% | To recent low | 8% | Market Cap | $1.904b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |